Efficacy and Safety of Variable-Dose Versus Continuous-Dose Abrocitinib Treatment in Patients with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis

• by Jonathan I. Silverberg, Eric L. Simpson, Saleem A. Farooqui, Gary Chan, Pinaki Biswas, Erman Güler

• May 20, 2026

IL-17, IL-23 Therapies Lead Psoriasis Care

Network meta-analysis suggests higher PASI 90 response rates with biologics vs oral systemic therapies

• by Andrea Surnit

• April 12, 2026

• 3 min

Top 10 Evidence-Based Essentials in Dermatology

A structured framework of guidelines, trials, therapies, and tools used in clinical practice

• by Conexiant News Staff

• April 24, 2026

• 3 min

Topical Postbiotics Show Promise for Acne, Eczema

Postbiotics linked to improvements in acne and eczema, with limited data in rosacea

• by Meg Barbor

• March 26, 2026

• 2 min